Self-Adhering Magnetic Device to Treat Corneal Exposure
Recruiting
N/A
Interventional Study
Paralytic Lagophthalmos
Corneal Exposure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 25 (estimated)
- Sponsor
- University of Illinois at Chicago · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Males and females ages 18-80 years old.
* Patients with recent corneal abrasion and no signs of infection in the examination
* Patients with lagophthalmos
* Normal Controls
Exclusion Criteria:
* Individuals with adhesive or tape allergies.
* Individuals with a history of met…
Contacts